***Background.*** The purpose of this study was to identify factors associated with relapses or reinfections in patients with recurring *Clostridium difficile* infections (CDIs).

***Methods.*** From September 2008 to January 2012, cases with two or more isolates from consecutive CDI episodes were included. PCR-ribotyping and multilocus variable-number tandem-repeat analysis (MLVA) were performed using paired isolates.

***Results.*** Among 473 patients, 68 (14.4%) experienced 1--5 recurrences. Fifty-one of these with two or more isolates from consecutive CDI episodes were included in the study; 25 (49 %) were classified as relapses and 26 (51%) as reinfections. Recurrence interval was shorter in relapse group (26.0 vs 67.5 *p* = 0.001), but more patients in reinfection group were hospitalized during recurrence interval (53.8% vs 8.0%, *p* \<0.001). Relapse rates in infections by ribotype 017, ribotype 018 and other ribotypes were 63.6%, 63.6% and 22.2%, respectively (*p* = 0.274, *p* = 0.069, and *p* = 0.005). In multivariate logistic regression, infections by ribotype 017 and 018 were associated with CDI relapse (OR 4.77, 95% CI 1.02-22.31, *p* =0.047; OR 11.49, 95% CI 2.07-63.72, *p* =0.005). Conversely, admission during recurrence interval lowered relapse (OR 0.044, 95% CI 0.006-0.344, *p* =0.003).

***Conclusion.*** In conclusion, relapse was more likely when infection was caused by PCR ribotype 017 and 018.
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